Caffeine Terminated Phase 2 Trials for Dyspnea Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02311088Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor